Tag: gilead remdesivir

Edesa Biotech NASDAQ EDSA Health Canada COVID19

Edesa Biotech, Inc. (NASDAQ: EDSA) Surges 100% After Receiving Approval to Begin COVID-19 Phase 2/3 Clinical Trials from Health Canada

by admin

June 15, 2020

Edesa Biotech, Inc. (NASDAQ: EDSA) is a clinical-stage biopharmaceutical company that specializes in treatments for dermatological and gastrointestinal ailments. Shares ...

No Result

View All Result

Home
News
Video
Stock and Crypto Screener

Tag: gilead remdesivir

Edesa Biotech, Inc. (NASDAQ: EDSA) Surges 100% After Receiving Approval to Begin COVID-19 Phase 2/3 Clinical Trials from Health Canada

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

It’s All Greek to Me: What Are Option Greeks and How Do They Impact Traders?

Unleashing the Power of 5G: The Future of Mobile Technology

Recent News

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

Categories

Site Navigation